Skip to content
value.today

NewLeaf Symbiotics, Inc.

🇺🇸 St. Louis, Missouri, USAAgricultureFounded 2011
Total raised
$113 M
5 rounds on record
Latest round
$47 M
Dec 2023
First round on record
Jan 2013
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of NewLeaf Symbiotics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2023$47 MNo. 5$10 to $50 million

NewLeaf Symbiotics, Inc.: Raise no. 5, Dec 2023

Investors in this round

9 investors had bought by the notice of Dec 21, 2023: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$47 M of $47 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Aaron Kelley · Executive Officer
  • Brent Smith · Executive Officer, Director
  • David Flack · Executive Officer
  • David Purschke · Executive Officer
  • Michael Frodyma · Executive Officer
  • Molly Edwards · Executive Officer
  • Natalie Breakfield · Executive Officer
  • Shawn Semones · Executive Officer
  • Stephen Kahn · Executive Officer, Director
  • David Prend · Director
  • John Pasquesi · Director
  • Paul Schickler · Director
  • Sanjeev Krishnan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Molly Edwards, General Counsel and Vice President of Human Resources. Source: SEC Form D, newest notice filed Dec 21, 2023. Read the notice at the SEC.

equitySEC
Feb 2020$21 MNo. 4$10 to $50 million

NewLeaf Symbiotics, Inc.: Raise no. 4, Feb 2020

Investors in this round

6 investors had bought by the notice of Feb 25, 2020: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$21 M of $35 M offered; $14 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$150,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Aaron Kelley · Executive Officer
  • Desmond Jimenez · Executive Officer
  • Janne Kerovuo · Executive Officer
  • Matt Helms · Executive Officer
  • Molly Edwards · Executive Officer
  • Natalie Breakfield · Executive Officer
  • Stephen Kahn · Executive Officer, Director
  • David Prend · Director
  • John Pasquesi · Director
  • Paul Schickler · Director
  • Sanjeev Krishnan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Pickwick Capital Partners, LLC (CRD 130672) · White Plains, New YorkSold in CA, IL, MA, MO, NC, NY

Remarks in the notice

  • On fees: “Finders' fees paid in connection with sales through February 14, 2020.”

Signed by Stephen Kahn, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 25, 2020. Read the notice at the SEC.

equitySEC
Jun 2017$24 MNo. 3$10 to $50 million

NewLeaf Symbiotics, Inc.: Raise no. 3, Jun 2017

Investors in this round

15 investors had bought by the notice of Jul 10, 2017: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$24 M of $30 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Desmond Jimenez · Executive Officer
  • Doug Bryant · Executive Officer
  • Janne Kerovuo · Executive Officer
  • Michael McFatrich · Executive Officer
  • Stephen Kahn · Executive Officer
  • Thomas Laurita · Executive Officer, Director
  • John Pasquesi · Director
  • Stoddard Wilson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Thomas Laurita, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 10, 2017. Read the notice at the SEC.

equitySEC
Sep 2014$17 MNo. 2$10 to $50 million

NewLeaf Symbiotics, Inc.: Raise no. 2, Sep 2014

Investors in this round

16 investors had bought by the notice of Sep 15, 2014: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $17 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Desmond Jimenez · Executive Officer
  • Doug Bryant · Executive Officer
  • Gregg Bogosian · Executive Officer
  • Stephen Kahn · Executive Officer, Director
  • Thomas Laurita · Executive Officer, Director
  • Todd Mockler · Executive Officer
  • Daniel Hullah · Director
  • Jason Wrone · Director
  • Keith Gillard · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen Kahn, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 15, 2014. Read the notice at the SEC.

equitySEC
Jan 2013$5 MNo. 1$2 to $10 million

NewLeaf Symbiotics, Inc.: Raise no. 1, Jan 2013

Investors in this round

4 investors had bought by the notice of Jan 18, 2013: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $6 M offered; $1 M still to sell
Smallest investment taken
$50,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$316,250
Finders' fees
none
Paid to its own people
$316,250 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Marc Vanacht · Executive Officer, Director
  • Marcus Jones · Executive Officer
  • Stephen Kahn · Executive Officer
  • Thomas Laurita · Executive Officer, Director
  • Mel Schuster · Director
  • Michael Bielski · Director
  • Richard Carlton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Prevail Capital LLC (CRD 141322) · Bedford, MassachusettsSold in IL, MA

Remarks in the notice

  • On the use of proceeds: “Stephen Kahn, an executive officer, is a principal of Prevail Capital LLC.”

Signed by Stephen Kahn, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 18, 2013. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • NewLeaf Symbiotics, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2023).

    SEC Form D · Dec 2023

  • The industry group it chose in its notices: Agriculture.

    SEC Form D · Dec 2023

That is all the official record says: NewLeaf Symbiotics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of NewLeaf Symbiotics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 16 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by NewLeaf Symbiotics, Inc.
NameRoleNamed in
Aaron KelleyExecutive officerDec 2023
Brent SmithExecutive officerDec 2023
David FlackExecutive officerDec 2023
David PurschkeExecutive officerDec 2023
Michael FrodymaExecutive officerDec 2023
Molly EdwardsExecutive officerDec 2023
Natalie BreakfieldExecutive officerDec 2023
Shawn SemonesExecutive officerDec 2023
Stephen KahnExecutive officerDec 2023
Desmond JimenezExecutive officerFeb 2020
Janne KerovuoExecutive officerFeb 2020
Matt HelmsExecutive officerFeb 2020
Doug BryantExecutive officerJul 2017
Michael McFatrichExecutive officerJul 2017
Thomas LauritaExecutive officerJul 2017
Gregg BogosianExecutive officerSep 2014
Todd MocklerExecutive officerSep 2014
Marc VanachtExecutive officerJan 2013
Marcus JonesExecutive officerJan 2013
Brent SmithDirectorDec 2023
David PrendDirectorDec 2023
John PasquesiDirectorDec 2023
Paul SchicklerDirectorDec 2023
Sanjeev KrishnanDirectorDec 2023
Stephen KahnDirectorDec 2023
Stoddard WilsonDirectorJul 2017
Thomas LauritaDirectorJul 2017
Daniel HullahDirectorSep 2014
Jason WroneDirectorSep 2014
Keith GillardDirectorSep 2014
Marc VanachtDirectorJan 2013
Mel SchusterDirectorJan 2013
Michael BielskiDirectorJan 2013
Richard CarltonDirectorJan 2013